AbbVie, Inc. (ABBV)
255.48
-2.67
(-1.03%)
USD |
NYSE |
Aug 28, 16:00
255.52
+0.04
(+0.01%)
After-Hours: 20:00
AbbVie Cash from Operations (Annual) : 19.03B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 19.03B |
| December 31, 2024 | 18.81B |
| December 31, 2023 | 22.80B |
| December 31, 2022 | 24.94B |
| December 31, 2021 | 22.78B |
| December 31, 2020 | 17.59B |
| December 31, 2019 | 13.32B |
| December 31, 2018 | 13.43B |
| December 31, 2017 | 9.96B |
| Date | Value |
|---|---|
| December 31, 2016 | 7.041B |
| December 31, 2015 | 7.535B |
| December 31, 2014 | 3.549B |
| December 31, 2013 | 6.267B |
| December 31, 2012 | 6.345B |
| December 31, 2011 | 6.247B |
| December 31, 2010 | 4.976B |
| December 31, 2009 | 5.367B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Biogen, Inc. | 2.205B |
| Gilead Sciences, Inc. | 10.02B |
| Regeneron Pharmaceuticals, Inc. | 4.979B |
| Amgen, Inc. | 9.958B |
| REGENXBIO, Inc. | -123.96M |